Related Experiment Video

Updated: Jun 12, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Notch signaling proteins: legitimate targets for cancer therapy

Zhiwei Wang1, Yiwei Li, Fazlul H Sarkar

  • 1Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 9374 Scott Hall, 540 E Canfield, Detroit, MI 48201, USA.

Current Protein & Peptide Science
|May 25, 2010
PubMed

Insights

The Notch signaling pathway regulates cell balance and is implicated in cancer development. Natural agents targeting Notch offer potential new therapeutic strategies for cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Proteins and peptides, such as growth factors and hormones, are crucial for cellular homeostasis.
  • The Notch signaling pathway regulates cell proliferation, differentiation, and apoptosis, maintaining cellular balance.
  • Deregulation of Notch signaling is linked to the development and progression of human malignancies.

Purpose of the Study:

  • To review the role of Notch signaling pathway proteins in cancer.
  • To explore how Notch pathway deregulation contributes to tumor development, progression, metastasis, and patient mortality.
  • To summarize natural agents as potential therapeutic strategies targeting Notch signaling for improved cancer treatment outcomes.

Main Methods:

  • Literature review focusing on Notch signaling in cancer.
  • Analysis of studies linking Notch pathway deregulation to tumor development and metastasis.
  • Compilation of information on natural Notch inhibitors and their therapeutic potential.

Main Results:

  • Notch signaling pathway proteins play critical roles in cellular homeostasis.
  • Deregulation of Notch signaling is involved in tumor development, progression, metastasis, and patient demise.
  • Natural agents targeting Notch signaling show promise as novel therapeutic strategies.

Conclusions:

  • The Notch signaling pathway is a significant factor in cancer development and progression.
  • Targeting Notch signaling, particularly with natural agents, presents a promising therapeutic avenue for cancer treatment.
  • Further research into Notch inhibitors could lead to improved treatment outcomes for cancer patients.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...